1. Small Molecule (NCE)
  2. Oral Administration Route
  3. Proof of Safety and Efficacy in Three Phase I/II Clinical Trials for AML, NSCLC and COVID
  4. IP Protection - Compound, Indications, Manufacturing

What is Antroquinonol?

Antroquinonol is a small molecule NCE with demonstrated activities both in-vivo and in-vitro against a number of malignancies, infectious diseases and neuro-degenerative diseases.

Antroquinonol is also an oral compound that have been proven to be both efficacious and safe in a number of Phase 1 and Phase 2 studies. Currently this compound have completed studies in Acute Myeloid Leukemia, Non-Small Cell Lung Cancer, COVID-19, Hepatitis B and others with good clinical efficacy. As of January 2023, a total of 427 patients have completed clinical studies.


For further information, please visit here.